June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Iris-sutured posterior chamber intraocular lens implants: visual outcomes and complications.
Author Affiliations & Notes
  • Daliya Dzhaber
    Cornea, Wilmer Eye Institute, Baltimore, Maryland, United States
  • Fares Abdulelah Alsaleh
    Cornea, Wilmer Eye Institute, Baltimore, Maryland, United States
  • Yassine Jamil Daoud
    Cornea, Wilmer Eye Institute, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Daliya Dzhaber, None; Fares Alsaleh, None; Yassine Daoud, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1164. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Daliya Dzhaber, Fares Abdulelah Alsaleh, Yassine Jamil Daoud; Iris-sutured posterior chamber intraocular lens implants: visual outcomes and complications.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1164.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : To report the predisposing risk factors, visual outcomes and intra-operative and post-operative complications of patients that received iris-sutured posterior chamber intraocular lens (IOL) in eyes with aphakia and malpositioned IOLs.

Methods : Retrospective chart review and data analysis of patients that underwent iris fixation of IOL for correction of aphakia, dislocated and subluxed IOLs. Data included clinical risk factors, associated eye conditions, pre-operative and post-operative vision, intraocular pressure (IOP), previous surgeries, concomitant procedures, intra-operative and post-operative complications including corneal edema, pupil irregularity, uveitis, hyphema, suprachoroidal hemorrhage, elevated IOP, secondary IOL dislocation, macular edema (ME), epiretinal membrane formation (EM), retinal detachment (RD) and endophthalmitis.

Results : 97 cases of iris-sutured posterior chamber IOLs were analyzed. Mean age was 68 years old. Length of follow-up ranged from 1 month to 3.5 years with a mean follow-up of 11 months. The most common associated eye condition was uveitis-glaucoma-hyphema syndrome in 11/97 (11.3%). The most common predisposing risk factors necessitating an iris-fixated IOL were trauma 21/97 (21.6%), pseudoexfoliation syndrome 13/97 (13.4%) and high myopia in 8/97 (8.2%). 89 eyes had previous cataract surgery, 7/97 (7.2%) had prior pars plana vitrectomy (PPV), 7/97 (7.2%) had prior glaucoma surgery, 3/97 (3%) had prior descemet’s stripping automated endothelial keratoplasty (DSAEK) and 3/97 (3%) had prior penetrating keratoplasty (PK). 45/97 (46.3%) underwent concurrent PPV, 8/97 (8.2%) had combined DSAEK surgery and 1/97 (1%) had a trabeculectomy revision. Mean pre-op best corrected visual acuity (BCVA) was 20/60 (range 20/20 to LP). Mean post-op BCVA was 20/40 (range 20/20 to LP). The most common post-operative complications included IOL dislocation in 10/97 (10.3%), elevated IOP in 5/97 (5.1%), hyphema 2/97 (2%), ME in 2/97 (2%), EM formation in 2/97 (2%), corneal edema in 1/97 (1%) requiring DSAEK. Glaucoma developed in 4 eyes postoperatively, 3 of which were medically managed. There were no cases of postoperative RD or endophthalmitis.

Conclusions : Iris-fixated posterior chamber IOLs can be a good treatment option for eyes with inadequate capsular support. In our study it led to long-term stability of the IOLs in 89.7% with few complications.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.